Biotech News
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
investors.fennecpharma.com2026-05-06 15:04 EST
NEW YORK , Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025 , pursuant to securities laws, it disposed of beneficial ownership of 1,000,000